Literature DB >> 16280358

Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.

Kirstin Veugelers1, Bruce Motyka, Ing Swie Goping, Irene Shostak, Tracy Sawchuk, R Chris Bleackley.   

Abstract

During granule-mediated killing by cytotoxic T lymphocytes or natural killer cells, the serine protease granzyme B enters the target cell by endocytosis and induces apoptosis. Previous studies suggested a role for the mannose 6-phosphate receptor, but further experiments with purified granzyme B indicated this was not essential. Additionally, it is now clear that grB is exocytosed from killer cells in a high-molecular-weight complex with the proteoglycan serglycin. Here granzyme B was delivered as a purified monomer, or in complex with either glycosaminoglycans or serglycin, and killing was evaluated. When granzyme B was a monomer, soluble mannose 6-phosphate had a limited impact, whereas apoptosis induced by the complexed grB was effectively inhibited by mannose 6-phosphate. Most importantly, when granzyme B and perforin were delivered together from granules, inhibition by mannose 6-phosphate was also observed. In pulldown assays mediated by the cation-independent mannose 6-phosphate receptor, granzyme B bound to the receptor more intensely in the presence of immobilized heparan sulfate. We therefore propose the model that under physiological conditions serglycin-bound granzyme B is critically endocytosed by a mannose 6-phosphate receptor, and receptor binding is enhanced by cell surface heparan sulfate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280358      PMCID: PMC1356574          DOI: 10.1091/mbc.e05-07-0631

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  52 in total

Review 1.  Lymphocyte-mediated cytotoxicity.

Authors:  John H Russell; Timothy J Ley
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin.

Authors:  Srikumar M Raja; Baikun Wang; Mandakini Dantuluri; Umesh R Desai; Borries Demeler; Katharina Spiegel; Sunil S Metkar; Christopher J Froelich
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

3.  Microanalysis of hyaluronan oligosaccharides by polyacrylamide gel electrophoresis and its application to assay of hyaluronidase activity.

Authors:  Mayumi Ikegami-Kawai; Tomoko Takahashi
Journal:  Anal Biochem       Date:  2002-12-15       Impact factor: 3.365

4.  Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation.

Authors:  Sunil S Metkar; Baikun Wang; Miguel Aguilar-Santelises; Srikumar M Raja; Lars Uhlin-Hansen; Eckhard Podack; Joseph A Trapani; Christopher J Froelich
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

5.  Electrostatic reversal of serine proteinase substrate specificity.

Authors:  A Caputo; J C Parrish; M N James; J C Powers; R C Bleackley
Journal:  Proteins       Date:  1999-06-01

6.  The overexpressed human 46-kDa mannose 6-phosphate receptor mediates endocytosis and sorting of beta-glucuronidase.

Authors:  H Watanabe; J H Grubb; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.

Authors:  B Motyka; G Korbutt; M J Pinkoski; J A Heibein; A Caputo; M Hobman; M Barry; I Shostak; T Sawchuk; C F Holmes; J Gauldie; R C Bleackley
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

8.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

Review 9.  Cytotoxic T lymphocytes: all roads lead to death.

Authors:  Michele Barry; R Chris Bleackley
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

Review 10.  Functional significance of the perforin/granzyme cell death pathway.

Authors:  Joseph A Trapani; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

View more
  28 in total

Review 1.  Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity.

Authors:  Louise D Archer; Kia J Langford-Smith; Brian W Bigger; James E Fildes
Journal:  J Inherit Metab Dis       Date:  2013-05-08       Impact factor: 4.982

2.  Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis.

Authors:  G G Jinesh; W Choi; J B Shah; E K Lee; D L Willis; A M Kamat
Journal:  Cell Death Differ       Date:  2012-11-23       Impact factor: 15.828

3.  Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.

Authors:  Rupal Ramakrishnan; Deepak Assudani; Srinivas Nagaraj; Terri Hunter; Hyun-Il Cho; Scott Antonia; Soner Altiok; Esteban Celis; Dmitry I Gabrilovich
Journal:  J Clin Invest       Date:  2010-03-15       Impact factor: 14.808

4.  QPY/RAH haplotypes of the GZMB gene are associated with natural killer cell cytotoxicity.

Authors:  Wataru Oboshi; Toru Watanabe; Keisuke Hayashi; Takehiro Nakamura; Nobuyasu Yukimasa
Journal:  Immunogenetics       Date:  2017-06-26       Impact factor: 2.846

5.  Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells.

Authors:  Scott N Furlan; Benjamin Watkins; Victor Tkachev; Sarah Cooley; Angela Panoskaltsis-Mortari; Kayla Betz; Melanie Brown; Daniel J Hunt; John B Schell; Katie Zeleski; Alison Yu; Cynthia R Giver; Edmund K Waller; Jeffrey S Miller; Bruce R Blazar; Leslie S Kean
Journal:  Blood       Date:  2016-10-06       Impact factor: 22.113

Review 6.  Therapeutic cancer vaccines in combination with conventional therapy.

Authors:  Mads Hald Andersen; Niels Junker; Eva Ellebaek; Inge Marie Svane; Per Thor Straten
Journal:  J Biomed Biotechnol       Date:  2010-06-29

Review 7.  Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases.

Authors:  Y Wang; R G MacDonald; G Thinakaran; S Kar
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

8.  Increased fibroblast chymase production mediates procollagen autophagic digestion in volume overload.

Authors:  Lianwu Fu; Chih-Chang Wei; Pamela C Powell; Wayne E Bradley; Sarfaraz Ahmad; Carlos M Ferrario; James F Collawn; Louis J Dell'Italia
Journal:  J Mol Cell Cardiol       Date:  2016-01-22       Impact factor: 5.000

Review 9.  Mannose 6-phosphate receptor targeting and its applications in human diseases.

Authors:  M Gary-Bobo; P Nirdé; A Jeanjean; A Morère; M Garcia
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  Invariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia.

Authors:  Woo-Yong Lee; Maria-Jesus Sanz; Connie H Y Wong; Pierre-Olivier Hardy; Aydan Salman-Dilgimen; Tara J Moriarty; George Chaconas; Adriana Marques; Roman Krawetz; Christopher H Mody; Paul Kubes
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.